Seoul Pharma Co. Ltd Capital Reinvestment Ratio
Seoul Pharma Co. Ltd capital reinvestment ratio. Seoul Pharma Co. Ltd (018680) has a Capital Reinvestment Ratio of 0.04x as of June 2025, meaning it reinvests 0% of its operating cash flow (₩2.07 Billion) in capital expenditures (₩89.75 Million). Check Seoul Pharma Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Seoul Pharma Co. Ltd (2009–2023)
Capital reinvestment ratio of Seoul Pharma Co. Ltd from 2009 to 2023. This chart tracks Seoul Pharma Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. Also explore net asset momentum of Seoul Pharma Co. Ltd to track the company's year-over-year net asset growth rate.
Seoul Pharma Co. Ltd Capital Reinvestment Ratio by Year (2009–2023)
Seoul Pharma Co. Ltd capital reinvestment ratio by year from 2009 to 2023. For the full cash flow conversion analysis, see 018680 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.36x | ₩5.26 Billion | ₩1.89 Billion | ▲ +207.5% |
| 2020 | 0.12x | ₩5.74 Billion | ₩671.25 Million | ▲ +119.1% |
| 2019 | 0.05x | ₩2.93 Billion | ₩156.43 Million | ▼ -94.6% |
| 2015 | 0.98x | ₩1.42 Billion | ₩1.40 Billion | ▼ -44.5% |
| 2014 | 1.77x | ₩1.48 Billion | ₩2.62 Billion | ▼ -9.0% |
| 2012 | 1.95x | ₩9.22 Billion | ₩17.95 Billion | ▲ +74.2% |
| 2011 | 1.12x | ₩4.86 Billion | ₩5.43 Billion | ▼ -77.4% |
| 2009 | 4.95x | ₩1.23 Billion | ₩6.11 Billion | — |